"These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss," Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview included in the Cure report, "maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well." Troubling Pattern in Patient Adherence to GLP-1 Drug Therapy Despite their effectiveness, adhering to the injectable drugs have proven challenging
M., & Pan, Y
Lancet 397:17361748
GLP-1 Coverage Cost-benefit Analysis
For adults, the common TGA pattern is this: these medicines may be used for chronic weight management in people with a BMI of 30 or more , or a BMI of 27 or more with at least one weight-related comorbidity such as hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes, depending on the product
Verified Buyer 5 mo ago Bottle was packed securely and the order process was easy